NL1024590A1 - Nieuwe injecteerbare depotpreparaten. - Google Patents

Nieuwe injecteerbare depotpreparaten.

Info

Publication number
NL1024590A1
NL1024590A1 NL1024590A NL1024590A NL1024590A1 NL 1024590 A1 NL1024590 A1 NL 1024590A1 NL 1024590 A NL1024590 A NL 1024590A NL 1024590 A NL1024590 A NL 1024590A NL 1024590 A1 NL1024590 A1 NL 1024590A1
Authority
NL
Netherlands
Prior art keywords
injectable depot
depot preparations
new injectable
new
preparations
Prior art date
Application number
NL1024590A
Other languages
English (en)
Other versions
NL1024590C2 (nl
Inventor
Jaymin Chandrakant Shah
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL1024590A1 publication Critical patent/NL1024590A1/nl
Application granted granted Critical
Publication of NL1024590C2 publication Critical patent/NL1024590C2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NL1024590A 2002-10-25 2003-10-22 Nieuwe injecteerbare depotpreparaten. NL1024590C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42147302P 2002-10-25 2002-10-25
US42147302 2002-10-25

Publications (2)

Publication Number Publication Date
NL1024590A1 true NL1024590A1 (nl) 2004-04-27
NL1024590C2 NL1024590C2 (nl) 2005-05-23

Family

ID=32176718

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1024590A NL1024590C2 (nl) 2002-10-25 2003-10-22 Nieuwe injecteerbare depotpreparaten.

Country Status (20)

Country Link
US (1) US20040138237A1 (nl)
EP (1) EP1575616A2 (nl)
JP (1) JP2006514923A (nl)
KR (1) KR20050055781A (nl)
CN (1) CN1849110A (nl)
AR (1) AR041722A1 (nl)
AU (1) AU2003267788A1 (nl)
BR (1) BR0315568A (nl)
CA (1) CA2503076A1 (nl)
MX (1) MXPA05002561A (nl)
NL (1) NL1024590C2 (nl)
NO (1) NO20052463L (nl)
PA (1) PA8586201A1 (nl)
PE (1) PE20040499A1 (nl)
PL (1) PL377679A1 (nl)
RU (1) RU2310450C2 (nl)
TW (1) TW200423941A (nl)
UY (1) UY28038A1 (nl)
WO (1) WO2004037289A2 (nl)
ZA (1) ZA200501921B (nl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2959893A1 (en) 2002-12-13 2015-12-30 DURECT Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
CA2537413A1 (en) * 2003-09-02 2005-03-10 Imran Ahmed Sustained release dosage forms of ziprasidone
PL1809329T3 (pl) 2004-09-17 2012-08-31 Durect Corp Kompozycja znieczulająca zawierająca saib o przedłużonym uwalnianiu do stosowania miejscowego
CA2598288A1 (en) * 2005-03-03 2006-09-14 Elan Pharma International Limited Nanoparticulate compositions of heterocyclic amide derivatives
US20080193542A1 (en) * 2005-04-13 2008-08-14 Pfizer Inc. Injectable Deopot Formulations and Methods For Providing Sustained Release of Nanoparticle Compositions
WO2006109177A1 (en) * 2005-04-13 2006-10-19 Pfizer Products Inc. Injectable depot formulations and methods for providing sustained release of poorly soluble drugs comprising nanoparticles
US20080305161A1 (en) * 2005-04-13 2008-12-11 Pfizer Inc Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
EA200800092A1 (ru) * 2005-06-20 2008-06-30 Элан Фарма Интернэшнл Лимитед Композиции в виде наночастиц и с контролируемым высвобождением, включающие арил-гетероциклические соединения
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
KR100908517B1 (ko) * 2006-07-04 2009-07-20 (주)아모레퍼시픽 호흡기계 약제 전달을 위한 서방형 다공성 미세입자 및 그제조 방법
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
ES2562878T3 (es) 2007-05-25 2016-03-08 Indivior Uk Limited Formulaciones de liberación sostenida de compuestos de risperidona
WO2009088414A2 (en) 2007-12-06 2009-07-16 Durect Corporation Oral pharmaceutical dosage forms
JP5643195B2 (ja) * 2008-06-16 2014-12-17 デビオファーム インターナショナル ソシエテ アノニム 濃縮オキサリプラチン溶液及びその調製方法
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
CN104688686A (zh) * 2015-02-10 2015-06-10 万全万特制药江苏有限公司 一种含有齐拉西酮及其盐的脂肪乳注射剂
WO2018015915A1 (en) * 2016-07-22 2018-01-25 Cadila Healthcare Limited A parenteral controlled release composition of an atypical antipsychotic agent
GB2579707A (en) 2018-10-15 2020-07-01 Avent Inc Compositions, systems, kits, and methods for neural ablation
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
UA57734C2 (uk) * 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
PT1073432E (pt) * 1998-04-14 2007-10-22 Gen Hospital Corp Utilização da d-alanina ou da d-serina para o tratamento da esquizofrenia
DE60001649T2 (de) * 1999-05-27 2003-08-21 Pfizer Prod Inc Ziprasidonsuspension
US6753011B2 (en) * 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
EP1383445A4 (en) * 2001-03-20 2005-04-13 Cydex Inc PREPARATION CONTAINING PROPOFOL AND SULFOALKYL ETHER CYCLODEXTRIN
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers

Also Published As

Publication number Publication date
MXPA05002561A (es) 2005-05-05
CA2503076A1 (en) 2004-05-06
RU2310450C2 (ru) 2007-11-20
PL377679A1 (pl) 2006-02-06
AR041722A1 (es) 2005-05-26
ZA200501921B (en) 2006-10-25
PE20040499A1 (es) 2004-08-18
RU2005112207A (ru) 2005-09-10
CN1849110A (zh) 2006-10-18
NO20052463L (no) 2005-05-23
EP1575616A2 (en) 2005-09-21
NL1024590C2 (nl) 2005-05-23
PA8586201A1 (es) 2004-09-16
JP2006514923A (ja) 2006-05-18
UY28038A1 (es) 2004-05-31
BR0315568A (pt) 2005-08-23
US20040138237A1 (en) 2004-07-15
WO2004037289A2 (en) 2004-05-06
AU2003267788A1 (en) 2004-05-13
WO2004037289A3 (en) 2005-12-01
TW200423941A (en) 2004-11-16
KR20050055781A (ko) 2005-06-13

Similar Documents

Publication Publication Date Title
NL1024590A1 (nl) Nieuwe injecteerbare depotpreparaten.
NO20033179L (no) Injiserbar depotblanding
NO20053248D0 (no) Kerosenblanding.
NL1026074A1 (nl) Nieuwe Farmaceutica.
NL1027568A1 (nl) Nieuwe farmaceutica.
NO20052991D0 (no) Kinazolinforbindelser.
BR0305668B1 (pt) compressor.
NO20052248D0 (no) Svivelstykkesystem.
NO20051500D0 (no) Substituerte heterocyklylpyrimidiner.
NO20051497D0 (no) Beta-laktamaseinhibitorprodrug.
ITMI20032170A1 (it) Tagliacimosse.
NL1025116A1 (nl) Nieuwe farmaca.
ITMI20030916A1 (it) Lancetta.
NL1025055A1 (nl) Verbeterd lampontwerp.
ES1052590Y (es) Quiosco-consigna.
ES1052102Y (es) Portallave retractil.
ITMO20020032U1 (it) Bilanciere con fulcro oscillante.
ES1052131Y (es) Luminaria estanca mejorada.
ITTO20020777A1 (it) Carrello elevatore.
ES1053652Y (es) Luminaria empotrable.
ES1052654Y (es) Cubitera.
ES1052938Y (es) Cantonera.
ES1052945Y (es) Contraventana.
ES1052029Y (es) Balin-proyectil.
ES1052011Y (es) Espetero.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20050118

PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20080501